Document is current
Any future updates will be listed below
-
Authors
Sobanjo-ter Meulen, Ajoke
Gutierrez, Aura V.
Ruiz, Ornella
Eeuwijk, Jennifer
Vroling, Hilde
Kanesa-thasan, Niranjan
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 12 May 2025
Accepted: 19 June 2025
First Online: 31 July 2025
Declarations
:
: Aura V. Gutierrez, Ornella Ruiz, Jennifer Eeuwijk, and Hilde Vroling were all under the employ of P95 Clinical & Epidemiology Services when they carried out the literature review, a project which was financially supported by Icosavax, a member of the AstraZeneca group. During the completion of the manuscript, Aura V. Gutierrez became affiliated with Odds Epidemiology, Bogota, Colombia, while Hilde Vroling joined the Health Council of the Netherlands, Den Haag, the Netherlands. Ajoke Sobanjo-ter Meulen and Niranjan Kanesa-thasan are employees and stockholders of Icosavax, a member of the AstraZeneca group.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
